$EXC Headlines Safe and steady ETFs for the new year

New Post Public Reply Private Reply Replies (0) Message Board

Dec 9, 2013 at 1:48 PM

$EXC Headlines

Safe and steady ETFs for the new year 12:03 p.m. Today - Jim Lowell
Exelon profit soars on hedging gains, lower costs 4:19 p.m. Oct. 30, 2013 - MarketWatch.com
Apple extends gains on price target hike 2:47 p.m. Oct. 16, 2013 - Sue Chang
The days of easy money may be over 12:28 p.m. Sept. 20, 2013 - Mark Hulbert
Wednesday’s movers: Facebook, Symantec 3:43 p.m. July 31, 2013 - Maria LaMagna
Exelon profit up 72% on growth at ComEd utility 8:23 a.m. July 31, 2013 - MarketWatch.com
Comcast, CBS shares in focus Wednesday 7:53 a.m. July 31, 2013 - Wallace Witkowski
Utility stocks drop as bond yields rise 5:11 p.m. May 28, 2013 - Wallace Witkowski
U.S. stocks rise; optimism ‘as high as a kite’ 4:25 p.m. May 28, 2013 - Kate Gibson
Tuesday’s movers: Netflix slumps more than 6% 3:34 p.m. May 28, 2013 - Sue Chang
Utilities hit as Exelon, FirstEnergy downgraded 10:27 a.m. May 28, 2013 - Wallace Witkowski
Exelon swings to loss on mark-to-market expenses 7:32 a.m. May 1, 2013 - MarketWatch.com
First Solar shares hammered on outlook 6:45 p.m. Feb. 26, 2013 - Matt Andrejczak
Exelon net off 38% on higher costs; cuts dividend 8:31 a.m. Feb. 7, 2013 - MarketWatch.com
Chevron weighs on Dow as energy stocks drop 4:47 p.m. Dec. 3, 2012 - Steve Gelsi
WPX Energy, Cabot Oil pace energy stock gains 10:00 a.m. Dec. 3, 2012 - Steve Gelsi
Exelon to pay $400,000 to settle DOJ probe 10:34 a.m. Nov. 15, 2012 - MarketWatch.com
Utilities power higher, leading S&P 500 sectors 12:10 p.m. Nov. 13, 2012 - blogs.marketwatch.com
Updates, advisories and surprises 4:01 p.m. Nov. 1, 2012 - MarketWatch
PSEG drops after Sandy; WPX Energy weighs 3:54 p.m. Nov. 1, 2012 - Steve Gelsi

Surprises From the Energy Front 4:00 p.m. Dec. 6, 2013 - RealMoney.com
Exelon: Selling At 10-Year Lows 5:47 p.m. Dec. 5, 2013 - Seeking Alpha
Exelon Corp (EXC): Today's Featured Utilities Winner 5:02 p.m. Dec. 3, 2013 - TheStreet.com
5 Hold-Rated Dividend Stocks: HME, PDM, NS, EXC, BBEP 10:31 a.m. Dec. 2, 2013 - TheStreet.com
Exelon: The Healthiest Patient In A Mental Institution 10:18 a.m. Dec. 2, 2013 - Seeking Alpha
Regulated Utilities To Outperform Diversified Utilities 5:25 a.m. Dec. 1, 2013 - Seeking Alpha
Not All Utilities Are Alike 2:00 p.m. Nov. 29, 2013 - RealMoney.com
Exelon Corp.: Difficult Time Ahead 3:59 a.m. Nov. 29, 2013 - Seeking Alpha
ModernGraham Valuation Of Exelon 1:39 p.m. Nov. 28, 2013 - Seeking Alpha
Do Not Chase (Mindlessly) The Dividend Yields 9:16 a.m. Nov. 27, 2013 - Seeking Alpha
Exelon Corp (EXC): Today's Featured Utilities Laggard 5:01 p.m. Nov. 26, 2013 - TheStreet.com
Don't Believe This Balderdash on Electric Costs 9:30 a.m. Nov. 26, 2013 - RealMoney.com
Stocks Hitting 52-Week Lows 9:27 a.m. Nov. 25, 2013 - benzinga.com
Exelon, Entergy: Low-Cost Merchant Power Producers For A Market Turn 6:18 p.m. Nov. 21, 2013 - Seeking Alpha
Nuclear power operators win $750M reprieve on court decision 2:45 p.m. Nov. 20, 2013 - Seeking Alpha
Top 5 Yielding Hold-Rated Stocks: NTI, DFT, BBEP, EXC, MFA 10:30 a.m. Nov. 20, 2013 - TheStreet.com
A Huge Carve-Out for Solar Energy 4:00 p.m. Nov. 19, 2013 - RealMoney.com
Going Off the Grid 4:05 p.m. Nov. 18, 2013 - Barrons.com
Entergy: A Speculative Buy For Utility Income Seekers 11:50 a.m. Nov. 15, 2013 - Seeking Alpha
Constellation Announces Power Supply Agreement with City of Chicago 8:15 a.m. Nov. 14, 2013 - benzinga.com

Leadership Changes, Community Support Programs, Dividends, Financial Results Schedules, and Renewable Energy Proposals - Research Report on Southern Company, Exelon, Westar, FuelCell, and PNM 8:00 a.m. Today - PR Newswire
PECO Power Week Provides up to 90 Percent Savings for Philadelphia Orchestra Concerts 1:22 p.m. Dec. 5, 2013 - BusinessWire
Constellation Customers Giving Back: Company Announces Community Champions Grant Recipients 10:00 a.m. Dec. 3, 2013 - BusinessWire
Smart Grid Program Supported 2,800 Jobs in Third Quarter 9:35 a.m. Dec. 3, 2013 - PR Newswire
PECO Inspects Electrical Equipment to Ensure Reliable Service During Holiday Season 5:09 p.m. Dec. 2, 2013 - BusinessWire
Technical Research on Equities: Exelon Corp., CenterPoint Energy, Public Service Enterprise Group, and PNM Resources 8:46 a.m. Dec. 2, 2013 - PR Newswire
Give the Gift that's Warm and Bright This Holiday Season with PECO Smart Gift of Energy 8:00 a.m. Nov. 29, 2013 - BusinessWire
Exelon Says Competitive Markets Are Most Efficient Way to Ensure a Sustainable Energy Future 2:51 p.m. Nov. 21, 2013 - BusinessWire
ComEd Upgrades and Improves Systems to Prepare for Winter Weather 1:00 p.m. Nov. 21, 2013 - PR Newswire
ComEd Restores More Than 99 Percent of Customers Affected by Sunday's Storm 5:05 p.m. Nov. 19, 2013 - PR Newswire
Constellation Announces 2013 E2 Energy to Educate Grant Recipients 10:00 a.m. Nov. 19, 2013 - BusinessWire
ComEd Restores More Than 90 Percent of Customers Affected by Sunday's Storm 1:20 p.m. Nov. 18, 2013 - PR Newswire
Exelon Joins Program to Expand Baltimore City Home Ownership 9:00 a.m. Nov. 18, 2013 - BusinessWire
Constellation Wins Unique Coal-Free Power Supply Agreement with City of Chicago 9:07 a.m. Nov. 14, 2013 - BusinessWire
Exelon Holds First Innovation Expo as Part of Emerging Technology Initiative 3:11 p.m. Nov. 7, 2013 - BusinessWire
Pre-Market Review: Exelon Corp., CenterPoint Energy Inc., Public Service Enterprise Group Inc., and PNM Resources Inc. 9:41 a.m. Nov. 5, 2013 - PR Newswire
Baltimore Gas and Electric Company Declares Quarterly Preference Dividends 6:08 p.m. Nov. 4, 2013 - BusinessWire
PECO Customers Must Act Now To Receive LIHEAP Grants This Season 3:19 p.m. Nov. 4, 2013 - BusinessWire
PECO Ready to Meet Customer Demand This Winter 4:08 p.m. Oct. 31, 2013 - BusinessWire
PECO Encourages Customers to Scare Away Vampire Energy this Halloween 9:53 a.m. Oct. 31, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Stavian Group Eyes AI-Driven Southeast Asia Growth

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...